Xuantai Pharmaceutical (688247)
SSE · 688247
Market Cap$3.6B
Revenue$432.2M
Listed OnSSE
Ticker688247
CEO / ExecMr. Yun Fang Larry
HeadquartersShanghai
MarketMainland China
Websitewww.sinotph.com
Overview
Sinotherapeutics Inc., a specialty pharmaceutical company, research, develops, manufactures, and commercializes generic and formulation products in China. The company's products are indicated for infection, oncology and rheumatology, gastroenterology and metabolism, neurology, cardiology, and nephrology. It offers posaconazole delayed-release tablets; olaparib, exemestane, and tofacitinib extended-release tablets; and mesalamine delayed-release, dapagliflozin and metformin hydrochloride sustaine
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.